Search Results for 'placebo trial'
placebo trial published presentations and documents on DocSlides.
Alpha Omega MACE: 14.0% with EPA-DHA vs. 13.8% with placebo (p = 0.93)
by delcy
MACE: 13.2% with ALA vs. 14.5% with placebo (p = 0...
Fludrocortisone does not reduce the risk of recurrent syncope at 12 months compared with placebo i
by delcy
syncope. Given the trend towards benefit though, i...
ASCEND Randomized placebo-controlled trial of aspirin 100 mg daily in 15,480 patients with diabetes and no baseline cardiovascular
by mitsue-stanley
ASCEND Randomized placebo-controlled trial of as...
Tranexamic acid, civilian trauma and the CRASH-2 trial
by celsa-spraggs
Ian Roberts. Tranexamic acid and bleeding. The ...
Tranexamic acid, civilian trauma and the CRASH-2 trial
by sherrill-nordquist
Ian Roberts. Tranexamic acid and bleeding. The ...
European Medicines Agency 7 Westferry Circus Canary Wharf London E14 4
by jasmine
ICH Topic E 10 Choice of Control Group in Clinical...
Phase II Clinical Trial Austin Goodrich and Laura Peterman
by della
Outline. Review of a phase I trial. What is a phas...
The Trust-TSC Phase 3 Clinical Trial for Seizures in TSC
by willow
Mary Kay Koenig, MD. Associate Vice Chair for Clin...
Recent U.S. Regulatory Efforts on Complex Innovative Clinical Trial Design
by bery
John Scott, Ph.D.. Director, Division of Biostatis...
New drugs, new hopes for systemic lupus erythematosus
by SocialButterfly
Dr. Konstantinos Tselios, MD, PhD. Assistant Profe...
Phase 2 Trial Evaluating the Effect of Dexpramipexole on Eosinophil Biomarkers and Lung Function in
by thomas
Professor Salman Siddiqui, Clinical Professor of A...
Dr Krishnadas. N C​ Associate Professor Neurology, MES Medical College
by emma
​. DM Neurology (2011-2014) - Government Medical...
Dupixent is indicated for the treatment of moderatetosevere atopic d
by bella
First targeted biologic for adults with moderate-t...
Update on Treatment of Myasthenia Gravis
by conchita-marotz
KUMC Neurology Grand Rounds. 07/29/2016. Richard...
Dabigatran in myocardial injury after noncardiac
by lois-ondreau
surgery. Dr. PJ Devereaux on behalf of . MANAGE I...
Have the OPTIMOX-2, CAIRO-3, COIN, DREAM and other recent t
by sherrill-nordquist
Yes . Deborah . Schrag. , MD, MPH. No. John L. Ma...
When is a meta-analysis helpful?
by sherrill-nordquist
EBM: 9/18/2012. Evidence-based medicine. 25 year ...
The Use of Vitamin D in Clinical Practice
by olivia-moreira
John J Cannell, MD. Executive Director, Vitamin D...
Clinical Trials Oct . 6, Lyon France
by wayne461
Birthe Lemley. Executive. Board . Member. of ENG...
Placebo Control Group The group of people in a drug trial who are not given the new
by cecilia
drug. Open . trial . Both patient and the doct...
Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial
by OneAndOnly
VA Cooperative Studies Program Trial # 578. Contra...
Friedreich’s ataxia research update
by emery
Dr Julie Greenfield. Forward with Hope . Overview....
Interprétation des essais cliniques pour la pratique médicale en oncologie
by erica
Michel Cucherat. Lyon. Liens d’intérêt en onco...
Reference based multiple imputation;
by liane-varnes
f. or sensitivity analysis of clinical trials wit...
Safety and acceptability trial of the dapivirine vaginal ring in U.S. adolescents
by ximena
K. Bunge. , L. Levy, D. Szydlo, J. Zhang, A. Gaur,...
 Opioid-sparing clinical trial objectives and outcomes: chronic pain
by pagi
Nathaniel Katz, MD, MS. Associate Professor of Ane...
Advances in the Multidisciplinary Management of Hepatocellular Carcinoma:
by Heartbreaker
Strategies for Incorporating Emerging. Immunothera...
A GLP-1 Receptor Agonist CV Outcomes Trial
by BadassBabe
Final Results. Background. Trends in the Prevalenc...
The Agency for Healthcare Research and Quality has not yet seen or ap
by della
IntroductionStudy Selection..........................